← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	Theme Stocks	% of Portfolio	Status
1951	SWM SeaCrest Wealth Management Purchase, New York	$0	-$221K	0	–	Closed
1952	SAM Seelaus Asset Management Chatham, New Jersey	$0	-$246K	0	–	Closed
1953	SCM Segantii Capital Management Hong Kong	$0	-$6.65M	0	–	Closed
1954	SFM Signet Financial Management Parsippany, New Jersey	$0	-$11K	0	–	Closed
1955	SCM Sirios Capital Management Boston, Massachusetts	$0	-$1.08M	0	–	Closed
1956	SLG Stanley-Laman Group Berwyn, Pennsylvania	$0	-$211K	0	–	Closed
1957	SRAM Stone Ridge Asset Management New York	$0	-$363K	0	–	Closed
1958	Summit Partners Public Asset Management Boston, Massachusetts	$0	-$5.12M	0	–	Closed
1959	SLF Sun Life Financial Toronto, Ontario, Canada	$0	-$107K	0	–	Closed
1960	TTSTC Texas Treasury Safekeeping Trust Company Austin, Texas	$0	-$988K	0	–	Closed
1961	TEE Tibra Equities Europe London, United Kingdom	$0	-$265K	0	–	Closed
1962	TVWM Tower View Wealth Management Shorewood, Wisconsin	$0	$0	1	0%	Maintained
1963	TC Truvestments Capital Sarasota, Florida	$0	-$98K	0	–	Closed
1964	TI TT International London, United Kingdom	$0	-$208K	0	–	Closed
1965	VCM Venator Capital Management Toronto, Ontario, Canada	$0	-$685K	0	–	Closed
1966	VAM Verity Asset Management Durham, North Carolina	$0	-$311K	0	–	Closed
1967	Washington Trust Westerly, Rhode Island	$0	-$553K	0	–	Closed
1968	WC Weil Company San Diego, California	$0	-$5K	0	–	Closed
1969	WCM Whitener Capital Management Rocky Mount, North Carolina	$0	-$5K	0	–	Closed
1970	WIM Woodford Investment Management London, United Kingdom	$0	-$26M	0	–	Closed